SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Utah Medical Products, Inc. UTMD NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Utah Medical Products, Inc. (UTMD) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $68.37. It has a SharesGrow Score of 66/100, indicating a above average investment profile with 4 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of UTMD = $106.22 (+55.4% from the current price, the stock appears undervalued).

Valuation: UTMD trades at a trailing Price-to-Earnings (P/E) of 18.8 (S&P 500 average ~25).

Financials: revenue is $39M, -9.4%/yr average growth. Net income is $11M, growing at -11.4%/yr. Net profit margin is 29.3% (strong). Gross margin is 51.6% (-10 pp trend).

Balance sheet: total debt is $225,000 against $119M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 37.62 (strong liquidity). Debt-to-assets is 0.2%. Total assets: $123M.

SharesGrow 7-Criteria breakdown: Value 75/100 (Pass), Growth 15/100 (Fail), Past 100/100 (Pass), Health 100/100 (Pass), Moat 35/100 (Fail), Future ?/100 (Fail), Income 85/100 (Pass).

UTMD SharesGrow Score Overview

68/100

SharesGrow Score

Above average fundamentals

View full scorecard →

VALUE 75/100

Valuation — P/E, PEG, Forward PEG

GROWTH 15/100

Financials — average growth

PAST 100/100

strong — trend

HEALTH 100/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 35/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 85/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — UTMD

UTMD trades at a trailing Price-to-Earnings (P/E) of 18.8 (S&P 500 average ~25). Forward PEG -7.29 — Peter Lynch undervalued (≤1.0). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

UTMD: -9.4%/yr revenue is, -11.4%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

UTMD: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet UTMD: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is 37.62 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

UTMD: Gross margin is 51.6% (-10 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 35/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

UTMD: Net profit margin is 29.3%. healthy (≥15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range51.26-68.71

Volume12.44K

Avg Volume (30D)15.1K

Market Cap$219.04M

Beta (1Y)0.35

Dividend Yield$1.2300

Share Statistics

EPS (TTM)3.41

Shares Outstanding$3.31M

IPO Date1999-03-08

Employees155

CEOKevin L. Cornwell

Financial Highlights & Ratios

Revenue (TTM)$38.52M

Gross Profit$19.88M

EBITDA$17.06M

Net Income$11.29M

Operating Income$11.4M

Total Cash$85.76M

Total Debt$225K

Net Debt$-85.53M

Total Assets$122.54M

Price / Earnings (P/E)20

Price / Sales (P/S)5.69

Analyst Forecast

Company Info

CountryUS

ExchangeNASDAQ Global Select

CurrencyUSD

ISINUS9174881089

Price Chart

UTMD

Utah Medical Products, Inc. ↗ · NASDAQ Global Select

Healthcare • Medical - Instruments & Supplies

51.26 52WK RANGE 68.71

People Also View

AptarGroup, Inc.

Merit Medical Systems, Inc.

ICU Medical, Inc.

LeMaitre Vascular, Inc.

AngioDynamics, Inc.

InfuSystem Holdings, Inc.

KORU Medical Systems, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message